FDCs
60 articles related to "FDCs"
-
MSF addresses study by Massachusetts General Hospital on implications of switching from branded to generic antiretrovirals for HIV
Study on generic antiretrovirals ignores fact that patents prevent use of more affordable patient-friendly combination drugs The just-released study led by Massachusetts General Hospital in the...
Statements, Speeches, Letters – Last updated 16 January 2013
msfaccess.org/content/msf-addresses-study-massachusetts-general-hospital-implications-switching-branded-generic-0 -
HIV in Zimbabwe: “We cannot normalise a situation that is not normal”
Mari Carmen Viñoles and Jean François Saint-Sauveur landed in Harare, the capital of Zimbabwe in April 2009, after several previous assignments with Médecins Sans Frontières...
Web article – Last updated 27 December 2012
msfaccess.org/content/hiv-zimbabwe-we-cannot-normalise-situation-not-normal -
MSF responds to Indonesia's intent to issue compulsory licences on 7 HIV drugs
On 3 September, the Government of Indonesia issued a 'government use' decree - a type of compulsory licence that lifts a patent restriction on generic production - on seven drugs used to treat...
Statements, Speeches, Letters – Last updated 12 October 2012
msfaccess.org/content/msf-responds-indonesias-intent-issue-compulsory-licences-7-hiv-drugs -
Middle-Income Countries Flex Muscles to Overcome Patents in Face of Unaffordable Drug Prices
Washington, DC, 25 July 2012 —Middle-income countries are increasingly taking measures to overcome the patents that price drugs out of reach, according to a new report released today from...
Press Release – Last updated 26 July 2012
msfaccess.org/about-us/media-room/press-releases/middle-income-countries-flex-muscles-overcome-patents-face -
Treating HIV in the developing world: getting ahead of the drug development curve
At the 2006 International AIDS Conference (http://www.aids2006.org/), an impressive range of new therapeutic developments for HIV/AIDS were described. Several new drugs, and new drug classes (entry...
In Medical Journals / Research Articles – Last updated 28 November 2006
msfaccess.org/content/treating-hiv-developing-world-getting-ahead-drug-development-curve -
MSF HIV/AIDS in Kenya: majority of patients with suspect Zidolam-N receive follow-up consultations
MSF has followed-up nearly 3,000 of the HIV/AIDS patients who received antiretroviral drugs (ARVs) from falsified batches and provided them with replacement ARVs. MSF is working hard to get in contact...
Statements, Speeches, Letters – Last updated 29 November 2011
msfaccess.org/content/msf-hivaids-kenya-majority-patients-suspect-zidolam-n-receive-follow-consultations -
Falsified Medicines Enter Supply Chain in Kenya
MSF is taking all measures to ensure adequate treatment and medical follow up for patients Nairobi, 30 September 2011 -- On 5th and 7th September, Médecins Sans Frontières (MSF) missions...
Press Release – Last updated 03 October 2011
msfaccess.org/about-us/media-room/press-releases/falsified-medicines-enter-supply-chain-kenya -
R&D: Developing simpler and more affordable treatment
ASAQ: A real step forward in malaria treatment The World Health Organization recommends artemisinin-based combinations, or ACTs, to treat malaria throughout much of the world. One barrier to implementation...
Static page – Last updated 28 July 2011
msfaccess.org/content/rd-developing-simpler-and-more-affordable-treatment -
Treating Malaria
Medical advances in treating malaria For decades, malaria was treated with drugs such as chloroquine or sulfadoxine-pyrimethamine (SP, often known by its brand name, Fansidar). However, after overwhelming...
Static page – Last updated 21 December 2011
msfaccess.org/content/treating-malaria -
AS/AQ Answers Needs of Malaria Patients
Why AS/AQ answers the needs of patients Many of the older drugs used to treat malaria like chloroquine are increasingly ineffective because of resistance. Newer treatment options...
Web article – Last updated 05 March 2007
msfaccess.org/content/asaq-answers-needs-malaria-patients
